<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Int. J. Public Health</journal-id>
<journal-title-group>
<journal-title>International Journal of Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Int. J. Public Health</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1661-8564</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1608765</article-id>
<article-id pub-id-type="doi">10.3389/ijph.2026.1608765</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Global Burden of Type 2 Diabetes Attributable to Behavioral Risks: Insights and Projections to 2050 Based on the Global Burden of Disease Study 2021</article-title>
<alt-title alt-title-type="left-running-head">Zhang et al.</alt-title>
<alt-title alt-title-type="right-running-head">Behavioral Risks and T2D Burden</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Guomiao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3089924"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mei</surname>
<given-names>Huiqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sheng</surname>
<given-names>Qichao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xinlv</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diwon</surname>
<given-names>Anthony</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yuxin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Ziyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xiaoyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Qingyang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Dapeng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mao</surname>
<given-names>Guangyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Shi</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Department of Epidemiology and Health Statistics, School of Public Health, Wenzhou Medical University</institution>, <city>Wenzhou</city>, <state>Zhejiang</state>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>State Key Laboratory of Cognitive Intelligence, University of Science and Technology of China</institution>, <city>Hefei</city>, <state>Anhui</state>, <country country="CN">China</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Department of Endocrinology, The Second Affiliated Hospital, School of Medicine, Zhejiang University</institution>, <city>Hangzhou</city>, <state>Zhejiang</state>, <country country="CN">China</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Department of Environmental Health Sciences, School of Public Health, University of Alberta</institution>, <city>Edmonton</city>, <state>AB</state>, <country country="CN">Canada</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Fang Shi, <email xlink:href="mailto:shifang@wmu.edu.cn">shifang@wmu.edu.cn</email>; Guangyun Mao, <email>mgy@wmu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-03-11">
<day>11</day>
<month>03</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>71</volume>
<elocation-id>1608765</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>06</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>08</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Zhang, Mei, Sheng, Chen, Zhang, Diwon, Wang, Chen, Wang, Zhang, Mao, Li, Zheng, Mao and Shi.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Zhang, Mei, Sheng, Chen, Zhang, Diwon, Wang, Chen, Wang, Zhang, Mao, Li, Zheng, Mao and Shi</copyright-holder>
<license>
<ali:license_ref start_date="2026-03-11">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>This study aims to provide a comprehensive analysis of the burden of Type 2 diabetes (T2D) attributable to behavioral risks.</p>
</sec>
<sec>
<title>Methods</title>
<p>Utilizing the Global Burden of Disease (GBD) 2021 data for secondary modeling, we analyzed the burden of T2D attributable to behavioral risks, stratified by age, gender, risk factors, and regions. A Bayesian age-period-cohort (BAPC) model projected burden trajectories from 2022 to 2050 under the continuation of historical trends.</p>
</sec>
<sec>
<title>Results</title>
<p>From 1990 to 2021, global deaths and DALYs of T2D attributable to behavioral risks increased by 133.87% and 187.68%. The greatest rises in ASMR and ASDR occurred in Eastern Europe, Central Asia, and Southern Sub-Saharan Africa. Dietary risks remained the primary contributor, whereas the T2D burden attributable to high alcohol use exhibited the steepest increase from 1990 to 2021. The global ASMR and ASDR increased exponentially with age and were consistently higher in males. Projections from the BAPC model indicate that ASDR is expected to continue increasing through 2050.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>T2D burden attributable to behavioral risks is increasing rapidly, underscoring the need for targeted interventions and public health education.</p>
</sec>
</abstract>
<kwd-group>
<kwd>type 2 diabetes</kwd>
<kwd>behavioral risks</kwd>
<kwd>GBD 2021</kwd>
<kwd>prevention strategy</kwd>
<kwd>projection</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by Wenzhou Scientific Research Project (grant numbers Y20240874); the Talent Research Start-up Project of Wenzhou Medical University (grant number QTJ23019); the Natural Science Foundation Project of Zhejiang Province (grant number LQ24H260007); the Project of College Students&#x2019; Science and Technology Innovation Activity Plan (New Seed Talent Plan) of Zhejiang Province (grant number 2024R413C088); Local Cooperation Project (Zhejiang Province Health and Elderly Care Service Talent Training Project) of China Scholarship Council (grant number 202408330441).</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="2"/>
<equation-count count="2"/>
<ref-count count="52"/>
<page-count count="12"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Diabetes mellitus is a significant global health challenge, currently ranking as the 8th leading cause of death and disability worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. Type 2 diabetes (T2D), which is primarily characterized by insulin resistance, accounts for 90%&#x2013;95% of all diabetes cases and significantly contributes to global mortality rates [<xref ref-type="bibr" rid="B2">2</xref>]. In 2021, T2D and its complications were responsible for an estimated 6.7 million deaths among adults aged 20 to 79 [<xref ref-type="bibr" rid="B3">3</xref>]. The age-standardized global prevalence rate of T2D is projected to increase by 61.2%, rising from 5.9% in 2021 to 9.5% in 2050, potentially affecting over 1.27 billion individuals [<xref ref-type="bibr" rid="B4">4</xref>].</p>
<p>Available evidence has demonstrated a significant link between behavioral risks and health loss in individuals with T2D. Adopting a balanced diet [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>], engaging in regular physical activity [<xref ref-type="bibr" rid="B7">7</xref>], and quitting smoking [<xref ref-type="bibr" rid="B8">8</xref>] have each been independently linked to a reduced risk of developing T2D. Meta-analyses of prospective cohort studies have found that individuals who consume moderate amounts of alcohol have a 30% lower incidence of diabetes than non-drinkers [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. Evidence suggests that structured behavioral interventions, such as increased physical activity and dietary modifications (e.g., higher fiber intake, reduced total calories, fats, and sugar-sweetened beverages), can reduce the incidence of T2D by 30%&#x2013;60% among prediabetic individuals [<xref ref-type="bibr" rid="B11">11</xref>]. Moreover, adopting preventive behaviors may decrease the incidence of diabetic retinopathy and cardiovascular mortality [<xref ref-type="bibr" rid="B12">12</xref>]. Therefore, understanding the burden of T2D attributable to behavioral risks and identifying these risks are crucial for developing targeted strategies to reduce the incidence and delay the progression of diabetes.</p>
<p>The Global Burden of Disease (GBD) Study 2021 offers a comprehensive analysis of the global, regional, and national burden of T2D attributable to various risk factors from 1990 to 2021. Among these, behavioral risks such as tobacco use, high alcohol consumption, dietary risks, and low physical activity have been increasingly recognized for their role in the development and progression of T2D [<xref ref-type="bibr" rid="B13">13</xref>]. As these behavioral risks are modifiable, health education at the individual level can support early prevention and delay the progression of T2D.</p>
<p>Although studies have reported on the global burden and trends in T2D from 1990 to 2021 [<xref ref-type="bibr" rid="B14">14</xref>], and on 88 risk factors in 204 countries and 811 subnational locations [<xref ref-type="bibr" rid="B15">15</xref>], there remains a gap in research specifically addressing the global burden and long-term trends of T2D attributable to behavioral risks. Using data from the GBD study 2021, this study aims to estimate the current global T2D burden associated with behavioral risks, predict its trends from 2022 to 2050, and explore differences in the burden across genders, ages and countries with varying socio-economic development levels. The findings may provide important evidence for the global targeted T2D prevention and control strategies.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Study Population and Data Collection</title>
<p>We conducted a global analysis of T2D attributable to behavioral risks using data from the Global Health Data Exchange query tool (GHDx, <ext-link ext-link-type="uri" xlink:href="https://ghdx.healthdata.org/gbd-results-tool">https://ghdx.healthdata.org/gbd-results-tool</ext-link>). Our metrics of interest included deaths, disability-adjusted life years (DALYs), the age-standardized mortality rate (ASMR), and the age-standardized disability-adjusted life years rate (ASDR), expressed per 100,000 people. The dataset covered various demographic groups across 204 countries, 21 global burden of disease regions, and 5 socio-demographic index (SDI) regions from 1990 to 2021. The SDI is a composite indicator reflecting a country&#x2019;s development level. A higher SDI value, ranging from 0 to 1, indicates greater socio-economic development [<xref ref-type="bibr" rid="B16">16</xref>]. Countries and regions were classified into 5 SDI groups: High, High-middle, Middle, Low-middle, and Low SDI.</p>
</sec>
<sec id="s2-2">
<title>Definition of T2D</title>
<p>T2D is a chronic condition occurring primarily in adults, characterized by insulin resistance or pancreatic insulin production deficiency. The GBD defines T2D as having a fasting plasma glucose level of &#x2265;7 mmol/L (126 mg/dL) or currently taking drugs or insulin therapy. According to the International Classification of Diseases (ICD), Ninth Revision, the code directly assigned to T2D deaths is 250, and the Tenth Revision code is E11 [<xref ref-type="bibr" rid="B17">17</xref>].</p>
</sec>
<sec id="s2-3">
<title>Estimation of Behavioral Risks</title>
<p>Data on behavioral risks were extracted from the GHDx following the definitions and classifications applied in the GBD 2021 study. The GBD study applies a hierarchical framework of risk factors, allowing both specific risks (e.g., Diet low in fruits, Diet low in vegetables) and aggregated categories (e.g., Dietary risks) to be evaluated simultaneously. The four behavioral risk categories for T2D included tobacco, high alcohol use, dietary risks, and low physical activity. In order to quantify the burden attributable to each behavioral risk, exposures were assessed relative to a theoretical minimum risk exposure level (TMREL)&#x2014;the counterfactual level of exposure that would minimize the risk of diabetes, according to epidemiological evidence [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B15">15</xref>]. On this basis, tobacco included both active smoking and exposure to secondhand smoke, with the TMREL defined as lifelong non-use. High alcohol use was defined as alcohol consumption in excess of the TMREL, the level of alcohol consumption at which all-cause risk is minimized [<xref ref-type="bibr" rid="B18">18</xref>]. However, the contribution of each risk factor to overall health loss varies by geography, age, period, and gender, indicating that the amount of alcohol that minimizes health loss also differs across these dimensions (<xref ref-type="sec" rid="s10">Supplementary Appendix S3</xref>). Dietary risks were subdivided into 7 components, each with a TMREL defined according to the GBD 2021 criteria. Protective factors included intake above the TMREL, such as fruits (&#x2265;340&#x2013;350&#xa0;g/day), vegetables (&#x2265;306&#x2013;372&#xa0;g/day), whole grains (&#x2265;160&#x2013;210&#xa0;g/day), and dietary fibre (&#x2265;22&#x2013;25&#xa0;g/day). Harmful factors were defined as intake below the TMREL, including processed meat (0&#xa0;g/day) and sugar-sweetened beverages (0&#xa0;g/day). A J-shaped association was observed between red meat intake and T2D, with the lowest risk occurring at 0&#x2013;200&#xa0;g/day. Low physical activity was assessed using metabolic equivalent minutes per week (MET-min/week) across leisure, occupational, household, and transport domains. The TMREL was set at 3,600&#x2013;4,400 MET-min/week, corresponding to the level associated with the lowest risk of adverse outcomes. Detailed descriptions of the risk factor estimation methodology are provided in <xref ref-type="sec" rid="s10">Supplementary Appendix S4</xref>.</p>
</sec>
<sec id="s2-4">
<title>Statistical Analysis</title>
<p>To appropriately measure the burden of T2D, we utilized the count of deaths, DALYs, ASMR, and ASDR attributed to behavioral risks with 95% uncertainty intervals (95% UIs). The 95% UI refers to the 2.5th and 97.5th percentiles of the 1,000 draw-level estimates for each parameter [<xref ref-type="bibr" rid="B19">19</xref>]. Countries and territories were divided into 21 GBD regions based on geographical similarities and were grouped into 5 SDI regions depending on their SDI levels. Age-standardized rates (ASR) were used to estimate the T2D burden attributable to behavioral risks at the global, regional, national, and territorial levels in 1990 and 2021. We calculated the Average Annual Percentage Changes (AAPCs) using the Joinpoint regression model, where the number of joinpoints was determined by the Permutation Test with a default maximum number of three [<xref ref-type="bibr" rid="B20">20</xref>]. The model calculations are as follows:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mi>ln</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>y</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>&#x3b1;</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi>&#x3b2;</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mi>x</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>&#x3b5;</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>Y</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>exp</mml:mi>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#x2211;</mml:mo>
<mml:msub>
<mml:mi>w</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:msub>
<mml:mi>&#x3b2;</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2211;</mml:mo>
<mml:msub>
<mml:mi>w</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>In the above equations, y represented ASMR or ASDR, x was the calendar year, &#x3b2;<sub>i</sub> indicated the slope coefficients of each segment in the expected year range, Y referred to AAPCs and w<sub>i</sub> was the length of each segment in the year range [<xref ref-type="bibr" rid="B21">21</xref>]. An increasing trend in ASMR or ASDR was indicated when both the AAPCs and its 95% confidence interval (95% CI) were greater than 0, and a decreasing trend when both were below zero. If the 95% CIs of AAPCs included 0, the ASMR and ASDR were considered stable.</p>
<p>Necessary stratified analyses by age and gender were additionally employed to identify sensitive populations for T2D attributable to behavioral risks. Restricted cubic spline (RCS) regression models were further performed to explore changes of ASMR and ASDR in 21 regions with different SDI levels from 1990 to 2021. The association of AAPCs with SDI in 2021 for ASMR and ASDR at the national level was further examined using locally estimated scatterplot smoothing (LOESS) regression.</p>
<p>To project future trends in T2D-related deaths and DALYs up to 2050, we utilized Bayesian age-period-cohort (BAPC) analysis, a widely applied approach in epidemiology for forecasting disease burden based on historical patterns. The BAPC model integrates both prior knowledge and observed data to provide probabilistic forecasts of disease burden, with particular attention to uncertainties [<xref ref-type="bibr" rid="B22">22</xref>]. Using data from 1990 to 2021, we trained the model and produced forecasts for 2050, with separate trend analyses for males and females. Uncertainty intervals were calculated using Bayesian inference, providing robust estimates for future trends [<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>].</p>
<p>Data management and analyses were performed using Joinpoint Regression Program (version 5.2.0) and R Statistical Software (version 4.4.1).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Global Trends in T2D Burden Attributable to Behavioral Risks From 1990 to 2021</title>
<p>Globally, deaths of T2D attributable to behavioral risks grew significantly (AAPCs &#x3d; 2.75, 95% CI: 2.58&#x2212;2.92, P &#x3c; 0.001), increasing from approximately 267,955 cases in 1990 to 626,661 cases in 2021, while the corresponding ASMR did not change much, with AAPCs of 0.06 (95% CI: &#x2212;0.06&#x2212;0.17, P &#x3e; 0.05). Furthermore, the DALYs of T2D attributable to behavioral risks also showed a substantial rise (AAPC &#x3d; 3.47, 95% CI: 3.40&#x2212;3.55, P &#x3c; 0.001), increasing from 10.49 million in 1990 to 30.19 million in 2021. In addition, the ASDR of T2D increased from 260.56 in 1990 to 348.52 per 100,000 people in 2021, with AAPCs of 0.96 (95% CI: 0.92&#x2212;1.00, P &#x3c; 0.001) (<xref ref-type="table" rid="T1">Table 1</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>The age-standardized mortality rate and age-standardized disability-adjusted life years rate of Type 2 diabetes attributable to behavioral risks in 1990 and 2021 at the global and regional level, and their Average Annual Percentage Changes from 1990 to 2021 (Global Burden of Disease Study, 21 Global Burden of Disease regions, 1990&#x2013;2021).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="3" align="left">Region</th>
<th colspan="4" align="center">Age-standardized rate per 100,000 people (95% UI)</th>
<th rowspan="2" colspan="2" align="center">Average annual percentage changes (AAPCs) from 1990 to 2021 (95% CI)</th>
</tr>
<tr>
<th colspan="2" align="center">1990</th>
<th colspan="2" align="center">2021</th>
</tr>
<tr>
<th align="center">Death</th>
<th align="center">DALYs</th>
<th align="center">Death</th>
<th align="center">DALYs</th>
<th align="center">Deaths rate</th>
<th align="center">DALYs rate</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Global</td>
<td align="center">7.40 (4.40,9.63)</td>
<td align="center">260.56 (147.88,350.55)</td>
<td align="center">7.42 (4.36,9.75)</td>
<td align="center">348.52 (192.6,486.92)</td>
<td align="center">0.06 (&#x2212;0.06,0.17)</td>
<td align="center">0.96 (0.92,1.00)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td colspan="7" align="left">SDI category</td>
</tr>
<tr>
<td align="left">&#x2003;High SDI</td>
<td align="center">6.36 (3.73,8.27)</td>
<td align="center">240.22 (138.35,322.50)</td>
<td align="center">4.43 (2.47,5.83)</td>
<td align="center">338.88 (179.05,489.92)</td>
<td align="center">&#x2212;1.17 (&#x2212;1.40, &#x2212;0.94)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.11 (1.06,1.17)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;High-middle SDI</td>
<td align="center">6.01 (3.63,7.68)</td>
<td align="center">229.04 (132.26,305.75)</td>
<td align="center">5.55 (3.30,7.31)</td>
<td align="center">296.49 (166.59,413.4)</td>
<td align="center">&#x2212;0.26 (&#x2212;0.54,0.02)</td>
<td align="center">0.87 (0.78,0.96)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Middle SDI</td>
<td align="center">7.70 (5.08,9.83)</td>
<td align="center">270.48 (169.47,360.66)</td>
<td align="center">8.26 (5.12,10.73)</td>
<td align="center">348.93 (207.63,483.24)</td>
<td align="center">0.26 (0.05,0.47)<sup>&#x2a;</sup>
</td>
<td align="center">0.83 (0.77,0.90)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Low-middle SDI</td>
<td align="center">9.59 (5.61,12.83)</td>
<td align="center">294.34 (170.88,394.29)</td>
<td align="center">12.30 (7.22,16.18)</td>
<td align="center">428.62 (245.72,591.23)</td>
<td align="center">0.82 (0.48,1.17)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.25 (1.16,1.34)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Low SDI</td>
<td align="center">12.35 (5.46,17.78)</td>
<td align="center">356.63 (155.58,515.83)</td>
<td align="center">12.32 (5.78,17.51)</td>
<td align="center">405.19 (178.58,588.02)</td>
<td align="center">0.02 (&#x2212;0.1,0.14)</td>
<td align="center">0.41 (0.36,0.46)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">Southeast Asia, East Asia, and Oceania Region</td>
<td align="center">5.32 (3.60,6.82)</td>
<td align="center">208.87 (133.76,276.57)</td>
<td align="center">5.28 (3.48,7.02)</td>
<td align="center">269.66 (163.88,377.05)</td>
<td align="center">&#x2212;0.01 (&#x2212;0.12,0.11)</td>
<td align="center">0.84 (0.75,0.93)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;East Asia</td>
<td align="center">3.93 (2.62,5.15)</td>
<td align="center">179.28 (111.10,245.21)</td>
<td align="center">3.78 (2.41,5.29)</td>
<td align="center">240.22 (138.68,345.19)</td>
<td align="center">&#x2212;0.07 (&#x2212;0.27,0.13)</td>
<td align="center">0.98 (0.83,1.14)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Southeast Asia</td>
<td align="center">9.45 (6.29,12.25)</td>
<td align="center">1,200.33 (668.94,1703.97)</td>
<td align="center">10.08 (6.9,13.12)</td>
<td align="center">368.75 (243.03,489.65)</td>
<td align="center">0.21 (0.15,0.28)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.69 (0.62,0.75)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Oceania</td>
<td align="center">41.46 (22.48,59.48)</td>
<td align="center">296.96 (189.13,384.59)</td>
<td align="center">42.72 (23.4,58.4)</td>
<td align="center">1,418.2 (783.5,1946.81)</td>
<td align="center">0.08 (0.04,0.13)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.52 (0.48,0.57)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">Central Europe, Eastern Europe, and Central Asia Region</td>
<td align="center">3.59 (1.95,4.70)</td>
<td align="center">192.26 (100.60,263.14)</td>
<td align="center">6.59 (3.54,8.74)</td>
<td align="center">333.81 (172.99,464.38)</td>
<td align="center">2.01 (1.23,2.79)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.81 (1.47,2.14)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Central Asia</td>
<td align="center">4.57 (2.20,6.07)</td>
<td align="center">213.81 (103.95,299.22)</td>
<td align="center">8.30 (4.00,11.45)</td>
<td align="center">431.71 (205.40,611.84)</td>
<td align="center">1.95 (1.61,2.29)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">2.25 (2.02,2.49)<sup>&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Central Europe</td>
<td align="center">6.24 (3.70,8.03)</td>
<td align="center">288.81 (166.32,388.98)</td>
<td align="center">6.74 (3.97,8.88)</td>
<td align="center">370.15 (208.19,510.70)</td>
<td align="center">0.31 (&#x2212;0.07,0.70)</td>
<td align="center">0.84 (0.65,1.04)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Eastern Europe</td>
<td align="center">1.99 (1.01,2.65)</td>
<td align="center">135.83 (65.38,191.87)</td>
<td align="center">5.88 (3.06,7.80)</td>
<td align="center">278.66 (141.11,387.50)</td>
<td align="center">3.57 (2.77,4.37)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">2.37 (2.10,2.64)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">High-income Region</td>
<td align="center">7.01 (4.09,9.09)</td>
<td align="center">249.92 (142.92,333.86)</td>
<td align="center">4.36 (2.40,5.73)</td>
<td align="center">329.75 (171.12,478.18)</td>
<td align="center">&#x2212;1.51 (&#x2212;1.67,-1.35)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.89 (0.85,0.94)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;High-income Asia Pacific</td>
<td align="center">3.98 (2.60,5.05)</td>
<td align="center">215.47 (134.47,289.12)</td>
<td align="center">1.61 (0.96,2.14)</td>
<td align="center">278.40 (149.26,417.13)</td>
<td align="center">&#x2212;0.77 (&#x2212;0.83,-0.71)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.76 (0.57,0.94)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Australasia</td>
<td align="center">5.86 (3.32,7.73)</td>
<td align="center">198.73 (109.99,270.37)</td>
<td align="center">4.30 (2.34,5.81)</td>
<td align="center">226.83 (114.23,329.02)</td>
<td align="center">&#x2212;0.91 (&#x2212;1.61,-0.21)<sup>&#x2a;</sup>
</td>
<td align="center">0.47 (0.08,0.87)</td>
</tr>
<tr>
<td align="left">&#x2003;Western Europe</td>
<td align="center">7.46 (4.42,9.66)</td>
<td align="center">230.68 (132.43,307.00)</td>
<td align="center">4.20 (2.35,5.54)</td>
<td align="center">257.73 (135.83,373.81)</td>
<td align="center">&#x2212;1.80 (&#x2212;1.94,-1.66)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.35 (0.27,0.43)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Southern Latin America</td>
<td align="center">11.31 (5.97,15.03)</td>
<td align="center">357.59 (187.90,484.87)</td>
<td align="center">7.61 (3.84,10.16)</td>
<td align="center">396.00 (195.75,578.06)</td>
<td align="center">&#x2212;1.37 (&#x2212;1.82,-0.92)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.41 (0.10,0.71)<sup>&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;High-income North America</td>
<td align="center">7.33 (4.07,9.57)</td>
<td align="center">287.58 (159.52,390.46)</td>
<td align="center">5.99 (3.21,7.88)</td>
<td align="center">458.82 (236.46,662.81)</td>
<td align="center">&#x2212;0.63 (&#x2212;0.86,-0.39)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.53 (1.40,1.65)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">Latin America and Caribbean Region</td>
<td align="center">14.39 (8.98,18.61)</td>
<td align="center">488.70 (292.06,658.81)</td>
<td align="center">12.53 (7.07,17.32)</td>
<td align="center">504.25 (264.33,724.80)</td>
<td align="center">&#x2212;0.40 (&#x2212;0.75,-0.06)<sup>&#x2a;</sup>
</td>
<td align="center">0.11 (&#x2212;0.11,0.34)</td>
</tr>
<tr>
<td align="left">&#x2003;Caribbean</td>
<td align="center">16.51 (9.46,22.14)</td>
<td align="center">539.22 (299.25,740.54)</td>
<td align="center">12.67 (7.02,17.81)</td>
<td align="center">582.15 (315.24,816.18)</td>
<td align="center">&#x2212;0.91 (&#x2212;1.61,-0.21)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.28 (0.10,0.46)<sup>&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Andean Latin America</td>
<td align="center">6.15 (3.30,8.69)</td>
<td align="center">204.16 (102.39,292.87)</td>
<td align="center">7.10 (3.69,10.43)</td>
<td align="center">289.75 (145.30,430.76)</td>
<td align="center">0.26 (0.05,0.47)<sup>&#x2a;&#x2a;</sup>
</td>
<td align="center">1.17 (1.01,1.32)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Central Latin America</td>
<td align="center">16.76 (10.69,21.85)</td>
<td align="center">575.90 (341.16,782.17)</td>
<td align="center">15.34 (8.32,21.56)</td>
<td align="center">603.82 (315.90,871.72)</td>
<td align="center">&#x2212;0.32 (&#x2212;0.65,0.01)</td>
<td align="center">0.16 (&#x2212;0.28,0.61)</td>
</tr>
<tr>
<td align="left">&#x2003;Tropical Latin America</td>
<td align="center">13.54 (8.89,17.35)</td>
<td align="center">458.54 (293.61,598.56)</td>
<td align="center">11.00 (6.36,14.70)</td>
<td align="center">439.39 (233.35,624.46)</td>
<td align="center">&#x2212;0.66 (&#x2212;1.09,-0.23)<sup>&#x2a;&#x2a;</sup>
</td>
<td align="center">&#x2212;0.11 (&#x2212;0.36,0.13)</td>
</tr>
<tr>
<td align="left">North Africa and Middle East Region</td>
<td align="center">10.09 (6.65,13.13)</td>
<td align="center">329.04 (201.72,440.92)</td>
<td align="center">11.92 (7.42,15.53)</td>
<td align="center">549.62 (330.72,755.36)</td>
<td align="center">0.58 (0.45,0.72)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.66 (1.61,1.71)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">South Asia Region</td>
<td align="center">9.22 (5.57,12.40)</td>
<td align="center">277.59 (162.97,371.59)</td>
<td align="center">11.72 (6.89,15.78)</td>
<td align="center">388.75 (220.16,538.70)</td>
<td align="center">0.89 (0.58,1.19)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.11 (1.00,1.21)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">Sub-Saharan Africa Region</td>
<td align="center">14.3 (6.45,20.41)</td>
<td align="center">389.59 (169.70,562.29)</td>
<td align="center">15.71 (7.46,22.03)</td>
<td align="center">459.01 (209.98,653.69)</td>
<td align="center">0.32 (0.24,0.41)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.53 (0.46,0.60)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Central Sub-Saharan Africa</td>
<td align="center">18.2 (6.83,28.03)</td>
<td align="center">489.77 (172.45,743.07)</td>
<td align="center">17.88 (6.06,27.87)</td>
<td align="center">547.58 (182.01,837.15)</td>
<td align="center">&#x2212;0.08 (&#x2212;0.2,0.05)</td>
<td align="center">0.38 (0.30,0.46)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Eastern Sub-Saharan Africa</td>
<td align="center">16.06 (5.63,23.97)</td>
<td align="center">425.82 (148.02,632.82)</td>
<td align="center">12.70 (5.14,18.91)</td>
<td align="center">354.88 (138.06,523.69)</td>
<td align="center">&#x2212;0.77 (&#x2212;0.83,-0.71)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">&#x2212;0.62 (&#x2212;0.69,-0.56)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Southern Sub-Saharan Africa</td>
<td align="center">18.57 (11.3,24.37)</td>
<td align="center">517.99 (307.12,685.71)</td>
<td align="center">31.02 (17.42,41.44)</td>
<td align="center">865.09 (479.81,1163.58)</td>
<td align="center">1.74 (1.14,2.35)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.73 (1.25,2.22)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">&#x2003;Western Sub-Saharan Africa</td>
<td align="center">10.50 (5.04,14.97)</td>
<td align="center">292.43 (135.59,415.94)</td>
<td align="center">12.80 (6.25,17.91)</td>
<td align="center">398.15 (185.64,577.07)</td>
<td align="center">0.64 (0.59,0.69)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.00 (0.95,1.04)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;P &#x3c; 0.05, &#x2a;&#x2a;P &#x3c; 0.01, &#x2a;&#x2a;&#x2a;P &#x3c; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In terms of 21 GBD regions, Southern Sub-Saharan Africa recorded the highest ASMR (31.02 per 100,000 people, 95% UI: 17.42&#x2013;41.44) and ASDR (865.09, 95% UI: 479.81&#x2212;1,163.58 per 100,000 people). High-income North America had a lower ASMR (5.99 per 100,000 people, 95% UI: 3.21&#x2013;7.88) but still bore a high ASDR burden (458.82 per 100,000 people, 95% UI: 236.46&#x2013;662.81). Eastern Europe showed the greatest increases in both ASMR (AAPCs &#x3d; 3.57, 95% CI: 2.77&#x2212;4.37, P &#x3c; 0.001) and ASDR (AAPCs &#x3d; 2.37, 95% CI: 2.10&#x2212;2.64, P &#x3c; 0.001) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>At the national level, Fiji had the highest ASMR (107.66 per 100,000 people) and ASDR (3,061.31 per 100,000 people) in 2021 (<xref ref-type="fig" rid="F1">Figures 1A,B</xref>). Russia had the fastest ASMR increase (AAPC &#x3d; 4.52), while Guatemala showed the largest increase in ASDR (AAPC &#x3d; 4.02) (<xref ref-type="fig" rid="F1">Figures 1C,D</xref>). India had the highest number of deaths, reaching 109,041.84, while China recorded the highest DALYs, amounting to 4,875,274.21 (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The age-standardized mortality rate and age-standardized disability-adjusted life years rate of Type 2 diabetes attributable to behavioral risks in 2021, and their Average Annual Percentage Changes from 1990 to 2021. <bold>(A)</bold> Age-standardized mortality rate; <bold>(B)</bold> Age-standardized disability-adjusted life years rate; <bold>(C)</bold> Average Annual Percentage Changes in age-standardized mortality rate; <bold>(D)</bold> Average Annual Percentage Changes in age-standardized disability-adjusted life years rate. ASMR, age-standardized mortality rate; ASDR, age-standardized disability-adjusted life years rate, AAPCs, Average Annual Percentage Changes (Global Burden of Disease Study, 204 countries or territories, 2021).</p>
</caption>
<graphic xlink:href="ijph-71-1608765-g001.tif">
<alt-text content-type="machine-generated">Four world maps labeled A to D display global distributions using color gradients. Panel A shows age-standardized mortality rates (ASMR) per one hundred thousand for 2021, with darker red regions indicating higher rates, especially in Africa and South America. Panel B presents age-standardized disability-adjusted life year rates (ASDR) per one hundred thousand for 2021, with high values concentrated in parts of Africa, South America, and Eastern Europe. Panel C illustrates average annual percentage changes (AAPCs) in ASMR from 1990 to 2021, where blue denotes decreases and red indicates increases, highlighting reductions in North and South America but increases in Russia and some African countries. Panel D maps AAPCs in ASDR from 1990 to 2021, with blue for declines and red for increases, showing notable decreases in South America and parts of Africa versus increases in Eastern Europe and Asia. Each panel includes a legend, scale, and annotated country examples.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<title>Global Trends in T2D Burden Attributable to Behavioral Risks by Region</title>
<p>Our analysis revealed dietary risks were the predominant modifiable factors associated with T2D globally, with ASMR of 4.52 (95% UI: 0.88&#x2212;7.36) and ASDR of 221.34 (95% UI: 47.97&#x2013;368.92) per 100,000 people (<xref ref-type="table" rid="T2">Table 2</xref>). Specifically, the highest ASMR related to dietary risks was observed in Oceania (26.27 per 100,000 people, 95% UI: 4.25&#x2013;44.14). Similarly, the highest ASDR was found in Oceania (862.05 per 100,000 people, 95% UI: 154.31&#x2013;1,465.63) (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). Dietary risks, which encompassed seven secondary behavioral risks in the GBD study, showed significant regional variations in their impact on T2D. Globally, high consumption of processed meat, along with low intake of whole grains, were the top three dietary risk factors (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>The global age-standardized mortality rate and age-standardized disability-adjusted life years rate of Type 2 diabetes attributable to behavioral risks in 1990 and 2021, and their Average Annual Percentage Changes from 1990 to 2021 (Global Burden of Disease Study, 1990&#x2013;2021).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="3" align="left">Behavioral risks</th>
<th colspan="4" align="center">Age-standardized rate per 100,000 people (95% UI)</th>
<th rowspan="2" colspan="2" align="center">Average annual percentage changes (AAPCs) from 1990 to 2021 (95% CI)</th>
</tr>
<tr>
<th colspan="2" align="center">1990</th>
<th colspan="2" align="center">2021</th>
</tr>
<tr>
<th align="center">Death</th>
<th align="center">DALYs</th>
<th align="center">Death</th>
<th align="center">DALYs</th>
<th align="center">Deaths rate</th>
<th align="center">DALYs rate</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-tobacco-smoke-level-2-risk">Tobacco</ext-link>
</td>
<td align="center">2.21 (1.43,2.94)</td>
<td align="center">90.76 (59.37,123.29)</td>
<td align="center">1.91 (1.20,2.62)</td>
<td align="center">102.08 (64.15,146.20)</td>
<td align="center">&#x2212;0.45 (&#x2212;0.53, &#x2212;0.38)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.38 (0.34,0.41)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-smoking-level-3-risk">&#x2003;Smoking</ext-link>
</td>
<td align="center">1.34 (1.10,1.56)</td>
<td align="center">57.55 (46.32,70.40)</td>
<td align="center">1.08 (0.89,1.31)</td>
<td align="center">62.48 (48.93,80.69)</td>
<td align="center">&#x2212;0.62 (&#x2212;0.71, &#x2212;0.53)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.27 (0.23,0.30)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-secondhand-smoke-level-3-risk">&#x2003;Secondhand smoke</ext-link>
</td>
<td align="center">0.96 (0.35,1.55)</td>
<td align="center">36.33 (13.08,61.04)</td>
<td align="center">0.87 (0.32,1.44)</td>
<td align="center">42.52 (15.35,72.77)</td>
<td align="center">&#x2212;0.27 (&#x2212;0.34, &#x2212;0.20)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.50 (0.46,0.55)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-dietary-risks-level-2-risk">Dietary risks</ext-link>
</td>
<td align="center">4.55 (0.86,7.35)</td>
<td align="center">159.96 (31.17,262.82)</td>
<td align="center">4.52 (0.88,7.36)</td>
<td align="center">221.34 (47.97,368.92)</td>
<td align="center">0.03 (&#x2212;0.10,0.15)</td>
<td align="center">1.07 (1.03,1.12)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-low-fruits-level-3-risk">&#x2003;Diet low in fruits</ext-link>
</td>
<td align="center">0.90 (0.14,1.58)</td>
<td align="center">33.53 (5.21,60.47)</td>
<td align="center">0.91 (0.14,1.59)</td>
<td align="center">39.14 (6.17,70.26)</td>
<td align="center">0.04 (&#x2212;0.10,0.17)</td>
<td align="center">0.51 (0.44,0.58)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-low-vegetables-level-3-risk">&#x2003;Diet low in vegetables</ext-link>
</td>
<td align="center">0.32 (&#x2212;0.12,0.67)</td>
<td align="center">9.73 (&#x2212;3.71,20.60)</td>
<td align="center">0.19 (&#x2212;0.07,0.42)</td>
<td align="center">6.87 (&#x2212;2.66,15.21)</td>
<td align="center">&#x2212;1.64 (&#x2212;1.78, &#x2212;1.50)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">&#x2212;1.15 (&#x2212;1.23, &#x2212;1.06)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-low-whole-grains-level-3-risk">&#x2003;Diet low in whole grains</ext-link>
</td>
<td align="center">1.26 (0.36,2.05)</td>
<td align="center">44.26 (13.14,74.13)</td>
<td align="center">1.21 (0.33,1.98)</td>
<td align="center">58.78 (17.32,98.86)</td>
<td align="center">&#x2212;0.07 (&#x2212;0.16,0.02)</td>
<td align="center">0.93 (0.90,0.96)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-high-red-meat-level-3-risk">&#x2003;Diet high in red meat</ext-link>
</td>
<td align="center">0.80 (&#x2212;0.11,1.76)</td>
<td align="center">28.96 (&#x2212;4.39,64.77)</td>
<td align="center">0.82 (&#x2212;0.12,1.81)</td>
<td align="center">44.10 (&#x2212;6.73,100.38)</td>
<td align="center">0.12 (&#x2212;0.06,0.31)</td>
<td align="center">1.39 (1.33,1.45)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-high-processed-meat-level-3-risk">&#x2003;Diet high in processed meat</ext-link>
</td>
<td align="center">1.50 (0.36,2.45)</td>
<td align="center">50.84 (12.44,85.40)</td>
<td align="center">1.37 (0.32,2.27)</td>
<td align="center">70.58 (17.11,120.71)</td>
<td align="center">&#x2212;0.32 (&#x2212;0.52, &#x2212;0.12)<sup>&#x2a;&#x2a;</sup>
</td>
<td align="center">1.06 (0.97,1.15)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-high-sugar-sweetened-beverages-level">&#x2003;Diet high in sugar-sweetened beverages</ext-link>
</td>
<td align="center">0.49 (0.25,0.70)</td>
<td align="center">17.76 (9.18,26.50)</td>
<td align="center">0.64 (0.33,0.93)</td>
<td align="center">35.02 (17.59,53.13)</td>
<td align="center">0.87 (0.75,0.99)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">2.22 (2.14,2.30)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-diet-low-fiber-level-3-risk">&#x2003;Diet low in fiber</ext-link>
</td>
<td align="center">0.24 (0.14,0.34)</td>
<td align="center">8.31 (4.74,12.08)</td>
<td align="center">0.21 (0.12,0.30)</td>
<td align="center">9.02 (4.97,13.46)</td>
<td align="center">&#x2212;0.52 (&#x2212;0.61, &#x2212;0.43)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">0.24 (0.20,0.29)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-high-alcohol-use-level-2-risk">High alcohol use</ext-link>
</td>
<td align="center">0.29 (0.10,0.54)</td>
<td align="center">8.89 (1.29,18.74)</td>
<td align="center">0.34 (0.12,0.64)</td>
<td align="center">15.43 (3.67,32.25)</td>
<td align="center">0.57 (0.26,0.88)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.83 (1.68,1.97)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">
<ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/research-analysis/diseases-injuries-risks/factsheets/2021-low-physical-activity-level-2-risk">Low physical activity</ext-link>
</td>
<td align="center">1.64 (0.71,2.51)</td>
<td align="center">46.06 (19.90,70.69)</td>
<td align="center">1.80 (0.79,2.75)</td>
<td align="center">64.27 (28.01,100.49)</td>
<td align="center">0.30 (0.16,0.43)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
<td align="center">1.10 (1.06,1.13)<sup>&#x2a;&#x2a;&#x2a;</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;P &#x3c; 0.05, &#x2a;&#x2a;P &#x3c; 0.01, &#x2a;&#x2a;&#x2a;P &#x3c; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The age-standardized mortality rate and age-standardized disability-adjusted life years rate of Type 2 diabetes attributed to four behavioral risks in 2021. <bold>(A)</bold> Age-standardized mortality rate per 100,000 people; <bold>(B)</bold> Age-standardized disability-adjusted life years rate per 100,000 people (Global Burden of Disease Study, 21 Global Burden of Disease regions, 2021).</p>
</caption>
<graphic xlink:href="ijph-71-1608765-g002.tif">
<alt-text content-type="machine-generated">Heatmap charts comparing health risk factors across global regions and socio-demographic index groups. Chart A shows age-standardized mortality rates (ASMR), and chart B shows age-standardized DALY rates (ASDR), for tobacco, dietary risks, high alcohol use, and low physical activity. Darker colors indicate higher values, with Oceania and Southern Sub-Saharan Africa exhibiting prominent hotspots for several risks in both charts. Numeric values are represented within each cell for each risk and region combination. A color scale legend is located between the panels.</alt-text>
</graphic>
</fig>
<p>Tobacco emerged as the second leading behavioral risk factor for T2D, with a global ASMR of 1.91 and ASDR of 102.08 per 100,000 people (<xref ref-type="table" rid="T2">Table 2</xref>). The highest ASMR (13.52 per 100,000 people, 95% UI: 7.63&#x2013;19.49) and ASDR (487.53 per 100,000 people, 95% UI: 290.44&#x2013;695.67) for T2D was observed in Oceania (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>). The risks of tobacco are made up of two main components, smoking and secondhand smoke. These factors showed similar geographic patterns, with the highest ASMR and ASDR in Oceania, Southern Sub-Saharan Africa, Caribbean and South Asia (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>).</p>
<p>While the overall burden of T2D attributable to high alcohol use was comparatively lower, there existed a notable increase in ASDR (AAPCs &#x3d; 1.83, 95% CI: 1.68&#x2212;1.97, P &#x3c; 0.001) (<xref ref-type="table" rid="T2">Table 2</xref>). Southern Sub-Saharan Africa (1.73 per 100,000 people, 95% UI: 0.62&#x2013;3.29) exhibited the highest ASMR for T2D linked to excessive alcohol intake. When considering ASDR, Southern Sub-Saharan Africa (47.59 per 100,000 people, 95% UI: 14.51&#x2013;94.26), Central Latin America (42.99 per 100,000 people, 95% UI: 8.48&#x2013;84.04), and High-Income North America (37.04 per 100,000 people, 95% UI: 7.55&#x2013;74.61) were detected as the regions most affected by alcohol-related T2D (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>).</p>
<p>Low physical activity was another key risk factor. Southern Sub-Saharan Africa had the highest ASMR (9.89 per 100,000 people, 95% UI: 4.18&#x2013;15.08) and ASDR (239.25 per 100,000 people, 95% UI:102.53&#x2013;361.94), followed closely by Oceania (ASMR: 8.68 per 100,000 people, 95% UI: 3.61&#x2212;13.94; ASDR: 268.48 per 100,000 people, 95% UI:110.53&#x2013;431.69) (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2</xref>).</p>
</sec>
<sec id="s3-3">
<title>Global Trends in T2D Attributable to Behavioral Risks by Gender and Age in 2021</title>
<p>In 2021, T2D deaths attributable to behavioral risks varied by age, peaking in males aged 70&#x2013;74 and females aged 80&#x2013;84 (<xref ref-type="fig" rid="F3">Figure 3A</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). The age-specific mortality rate increased exponentially with age, with higher rates observed in males than in females from age 30 onward (<xref ref-type="fig" rid="F3">Figure 3B</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S4</xref>). The age groups most affected by DALYs due to T2D were males at ages 60&#x2013;64 and females at ages 65&#x2013;69, with total DALYs of 16.12 million for males and 14.07 million for females (<xref ref-type="fig" rid="F3">Figure 3C</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S3</xref>). Consistent with the age-specific mortality rate, males showed higher age-specific DALYs rate than females, with rates increased substantially with age, except for males in the 90&#x2013;94 age group (<xref ref-type="fig" rid="F3">Figure 3D</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The number and rate of global burden of Type 2 diabetes attributable to behavioral risks by gender, age and risks in 2021. <bold>(A)</bold> Death numbers; <bold>(B)</bold> Deaths rate; <bold>(C)</bold> disability-adjusted life years; <bold>(D)</bold> disability-adjusted life years rate (Global Burden of Disease Study, 2021).</p>
</caption>
<graphic xlink:href="ijph-71-1608765-g003.tif">
<alt-text content-type="machine-generated">Four bar charts compare the impact of behavioral risks&#x2014;dietary risks, high alcohol use, low physical activity, and tobacco&#x2014;on mortality and disability-adjusted life years (DALYs) by age group and sex. Panel A shows number of deaths, Panel B shows death rate per one hundred thousand, Panel C shows number of DALYs, and Panel D shows DALY rate per one hundred thousand. Each chart displays data for males on the left and females on the right, with color-coded segments for each risk factor and a legend on the right.</alt-text>
</graphic>
</fig>
<p>Gender differences in major behavioral risks were evident: males had higher exposure to tobacco and high alcohol use, while females showed lower levels of physical activity (<xref ref-type="fig" rid="F3">Figure 3</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S5</xref>). In contrast, dietary risks were identified as the leading behavioral risk factor for T2D in both genders.</p>
</sec>
<sec id="s3-4">
<title>Differences in T2D Burden Attributable to Behavioral Risks Across SDI Levels</title>
<p>From 1990 to 2021, deaths and DALYs of T2D attributable to behavioral risks increased globally and across five SDI regions, highest in middle SDI regions (<xref ref-type="sec" rid="s10">Supplementary Figures S3A, B</xref>). Low-middle and low SDI regions had higher ASMRs and ASDRs than the global average (<xref ref-type="sec" rid="s10">Supplementary Figures S4A, B</xref>).</p>
<p>In the 21 GBD regions, T2D deaths and DALYs from behavioral risks followed an inverted U-shaped trend with SDI, peaking at 0.59 before declining (<xref ref-type="sec" rid="s10">Supplementary Figures S5A, B</xref>). It is worth noting that Southern Sub-Saharan Africa and Oceania had very high ASMR, with a significant increase between 1990 and 2021 (<xref ref-type="sec" rid="s10">Supplementary Figures S6A</xref>). Oceania had a particularly high ASDR of 1,418.20 (95% UI: 783.5&#x2013;1946.81) per 100,000 in 2021 and demonstrated a rapid upward trend (AAPC &#x3d; 0.52, 95% CI: 0.48&#x2013;0.57), surpassing regions with similar SDI (<xref ref-type="sec" rid="s10">Supplementary Figure S6B</xref>; <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>At the national level, a negative correlation between AAPCs and SDI was observed (ASMR: r &#x3d; &#x2212;0.503, P &#x3c; 0.001; ASDR: r &#x3d; &#x2212;0.274, P &#x3d; 0.002) when SDI was &#x2265;0.53. However, the association weakened when the SDI fell below 0.53 (ASMR: r &#x3d; 0.102, P &#x3d; 0.470; ASDR: r &#x3d; 0.105, P &#x3d; 0.458) (<xref ref-type="sec" rid="s10">Supplementary Figure S7</xref>).</p>
</sec>
<sec id="s3-5">
<title>BAPC Prediction of T2D Burden Attributable to Behavioral Risks</title>
<p>Over the next 30&#xa0;years, the projections indicate that the ASMR for both males and females will remain relatively stable (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). In contrast, the projected ASDR has a substantial increase for both genders, with a more pronounced rise in males. Specifically, the ASDR of T2D attributable to behavioral risks will increase from 392.30 (95% CI: 392.11&#x2013;392.49) in 2021 to 684.87 (95% CI: 207.38&#x2013;1,162.37) per 100,000 people by 2050 in males, and from 309.80 (95% CI: 309.64&#x2013;309.96) to 493.27 (95% CI: 191.90&#x2013;794.63) per 100,000 people in females (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). We also projected the global deaths and DALYs from 2022 to 2050. By 2050, the number of DALYs is expected to increase to 32.71 million in males and 23.56 million in females, highlighting a substantial disease burden (<xref ref-type="sec" rid="s10">Supplementary Figure S8</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The trends of age-standardized rates of Type 2 diabetes attributable to behavioral risks worldwide from 2022 to 2050 predicted by Bayesian age-period-cohort model. <bold>(A)</bold> Projected age-standardized mortality rate per 100,000 people for males. <bold>(B)</bold> Projected age-standardized mortality rate per 100,000 people for females. <bold>(C)</bold> Projected age-standardized disability-adjusted life years rate per 100,000 people for males. <bold>(D)</bold> Projected age-standardized disability-adjusted life years rate per 100,000 people for females. ASMR, age-standardized mortality rate; ASDR, age-standardized disability-adjusted life years rate (Global Burden of Disease Study, 1990&#x2013;2021).</p>
</caption>
<graphic xlink:href="ijph-71-1608765-g004.tif">
<alt-text content-type="machine-generated">Four-panel figure with line graphs labeled A, B, C, and D, each plotting age-standardized rate per one hundred thousand on the y-axis versus period from 1990 to 2050 on the x-axis. Black dots indicate observed values until 2021, followed by widening blue and grey cones representing forecast intervals. Panels A and B display relatively flat trends, while panels C and D show increasing rates and greater projected uncertainty over time. A vertical dashed line marks the transition from historical data to projections in all panels.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>This study presents an in-depth analysis of the global burden of T2D attributable to behavioral risks, revealing the predominant behavioral risks across genders, age groups, and regions with diverse socioeconomic development statuses. The deaths and DALYs of T2D attributable to behavioral risks have doubled over the past 30 years, and BAPC projections indicate that ASDR will continue to rise until 2050. This underscores the persistent and substantial influence of behavioral risks on the burden of T2D.</p>
<p>The geographical and national disparities in ASMR and ASDR attributable to behavioral risks were pronounced. In 10 of the 21 regions, ASMR increased, with Eastern Europe, Central Asia and Southern Sub-Saharan Africa at the forefront. Several factors were posited to underpin this trend, although their individual contributions remain speculative. The aging global population and the concomitant rise in diabetes prevalence are associated with premature mortality and disability, amplifying the DALY burden. Industrialization and modernization have fostered sedentary behaviors and poor dietary habits, potentially exacerbating an increase in behavioral risks and a heavier burden of T2D. Additionally, advancements in medical diagnostics may partly account for the heightened ASDR observed [<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. Oceania ranked highest in both ASMR and ASDR. Prior research indicates that the high diabetes prevalence, coupled with inadequate diabetes care, stems from complex structural influences [<xref ref-type="bibr" rid="B27">27</xref>]. Despite the highest diabetes prevalence, these Oceania countries often have the lowest treatment coverage, which is accompanied by disproportionately high ASDR and ASMR [<xref ref-type="bibr" rid="B28">28</xref>].</p>
<p>Our analysis identified four behavioral risks contributing to the ASMR and ASDR for T2D from 1990 to 2021: tobacco, dietary risks, high alcohol use and low physical activity. Modern lifestyle patterns&#x2014;characterized by excessive intake of high-calorie, highly processed foods and insufficient physical activity&#x2014;are closely associated with insulin resistance and dysregulated glucose homeostasis, which constitute the fundamental pathophysiological basis of T2D [<xref ref-type="bibr" rid="B29">29</xref>]. Dietary modifications can also alter the composition of the gut microbiota, thereby inducing low-grade systemic inflammation that further aggravates insulin resistance [<xref ref-type="bibr" rid="B30">30</xref>]. For individuals with T2D, improving dietary quality&#x2014;such as increasing fiber intake and reducing the consumption of processed and sugar-rich foods&#x2014;plays a critical role in both prevention and management of the disease [<xref ref-type="bibr" rid="B26">26</xref>]. Physical inactivity additionally heightens susceptibility to T2D by limiting skeletal muscle glucose uptake. Conversely, regular physical activity has been demonstrated to enhance insulin sensitivity and glucose metabolism both during and after exercise, thereby exerting protective effects on glucose homeostasis in individuals with T2D or at elevated risk [<xref ref-type="bibr" rid="B31">31</xref>]. Moreover, unhealthy behaviors such as smoking and excessive alcohol consumption have been well established as risk factors for T2D. Smoking, in particular, has been linked to increased T2D risk through mechanisms involving chronic low-grade inflammation, oxidative stress, and impaired insulin signaling. By contrast, the impact of alcohol consumption may vary across individuals, and further research is warranted to clarify these effects [<xref ref-type="bibr" rid="B32">32</xref>]. Studies have shown that alcohol consumption and the <italic>rs56221195</italic> genetic variant jointly influence insulin sensitivity and &#x3b2;-cell function [<xref ref-type="bibr" rid="B33">33</xref>]. In populations with high alcohol intake and metabolic vulnerability (e.g., elevated glucose or obesity), alcohol further exacerbates insulin resistance and impairs insulin secretion, while its impact on mortality and DALYs appears with a time lag [<xref ref-type="bibr" rid="B34">34</xref>]. In addition, GBD risk assessments are based on population-level exposure distributions. As global alcohol consumption rises&#x2014;particularly in low- and middle-income countries&#x2014;the overall population-level risk of T2D attributable to alcohol increases rapidly [<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B36">36</xref>]. Importantly, these findings highlight that adherence to a healthy lifestyle&#x2014;including smoking cessation and moderate alcohol intake&#x2014;can significantly reduce diabetes risk, lowering the incidence of latent autoimmune diabetes in adults (LADA) and T2D by 49% and 91%, respectively [<xref ref-type="bibr" rid="B37">37</xref>]. Collectively, these findings underscore that lifestyle factors shape T2D pathogenesis through intertwined metabolic, epigenetic, and inflammatory pathways, with dietary quality, physical activity, and weight management emerging as critical, modifiable targets for prevention and management.</p>
<p>The gender and age distribution of T2D deaths attributable to behavioral risks in 2021 revealed an association between advancing age and increased T2D mortality, peaking in women aged 80 to 84 and men aged 70 to 74. This aligns with previous studies [<xref ref-type="bibr" rid="B38">38</xref>&#x2013;<xref ref-type="bibr" rid="B40">40</xref>], which may be explained by older patients&#x27; compromised physical health and multiple chronic comorbidities. The gender disparity in T2D burden is particularly striking. Analyses covering 1990&#x2013;2021 and projections for the next 30 years both suggest that males consistently show higher mortality and DALY rates than females. This difference is largely attributed to gender-related behavioral and biological factors [<xref ref-type="bibr" rid="B41">41</xref>]. Smoking and high alcohol consumption, significant risk factors for T2D in males, partly contribute disproportionately to the T2D burden in this demographic.</p>
<p>The data also highlight a strong correlation between SDI values and the burden of T2D attributable to behavioral risks. High and high-middle SDI regions show lower ASMR and ASDR which may be related to improved socioeconomic conditions, as well as enhanced healthcare access and quality [<xref ref-type="bibr" rid="B42">42</xref>]. However, ASDR in high SDI regions increased rapidly from 1990 to 2021, and appeared to be associated with unhealthy diets, rising obesity, and global food system changes that promote energy-dense, nutrient-poor foods and limit physical activity [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>]. Aging populations in these regions further exacerbate the chronic disease burden [<xref ref-type="bibr" rid="B14">14</xref>]. Low-middle and low SDI regions had higher ASMRs than the global average. According to The Lancet Commission, in addition to underfunded and ill-prepared healthcare systems [<xref ref-type="bibr" rid="B3">3</xref>], low-income and middle-income countries were also beset by socioeconomic challenges such as poor nutrition, poverty, and physical inactivity [<xref ref-type="bibr" rid="B45">45</xref>].</p>
<p>This study represents a pioneering effort to quantify the global burden of T2D attributable to modifiable behavioral risks within the GBD framework. Despite the valuable insights provided by the GBD 2021 data, they share the limitations inherent to the GBD data. The accuracy of our estimates depends on the completeness and quality of country-level data, which may vary significantly [<xref ref-type="bibr" rid="B46">46</xref>]. To enhance robustness, GBD applies several methodological controls, including integration of multiple data sources, use of the Cause of Death Ensemble Model (CODEm) and DisMod-MR 2.1, as well as presentation of all estimates with 95% UIs [<xref ref-type="bibr" rid="B15">15</xref>]. To address data scarcity, we conduct analyses at the regional rather than country level, and cross-country comparisons should therefore be interpreted with caution. Additionally, for exposure measurement, this framework may omit relevant behavioral factors, and some data may be derived from sources with limited reliability, such as self-reports [<xref ref-type="bibr" rid="B47">47</xref>]. Furthermore, the GBD models quantify behavioral-attributable risk from available data, but these estimates are approximate and do not imply causal relationships [<xref ref-type="bibr" rid="B26">26</xref>]. Finally, the SDI employed in the GBD 2021 is a regional-level metric that does not consider potential patient-level confounders, limiting its applicability in individual risk assessment [<xref ref-type="bibr" rid="B16">16</xref>].</p>
<p>From a public health perspective, addressing the growing global burden of T2D requires comprehensive, evidence-based strategies and targeted public health interventions to promote healthy lifestyles and reduce exposure to modifiable behavioral risks. Strategies should include raising public awareness of the link between T2D and unhealthy dietary patterns, promoting balanced nutrition, and encouraging regular physical activity, alongside reshaping food environments through measures such as taxation of unhealthy foods and promotion of healthier options [<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B49">49</xref>]. Similarly, regulating alcohol availability, pricing, and marketing&#x2014;while integrating behavioral counseling and culturally tailored public awareness campaigns&#x2014;can help curb the escalating alcohol-related diabetes risk [<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>]. Lessons from tobacco control, including advertising bans and targeted demographic interventions, further illustrate the effectiveness of such regulatory and educational approaches in mitigating behavioral risk factors [<xref ref-type="bibr" rid="B52">52</xref>]. Integrating these strategies into national health policies and resource allocation frameworks provides actionable pathways to translate epidemiological evidence into sustainable prevention efforts and mitigate future disease burden.</p>
<sec id="s4-1">
<title>Conclusion</title>
<p>The present study reveals a marked escalation in the global burden of T2D attributable to behavioral risks, with a particularly pronounced increase in ASDR. Males, older adults, and populations in low and low-middle SDI regions are disproportionately affected. Among the risk factors identified, dietary risks contribute the most, while high alcohol use exhibits the steepest increase. By identifying the most influential behavioral risks, our study provides evidence to guide future research and policy formulation, underscoring the need for targeted interventions as well as comprehensive T2D prevention and control strategies.</p>
</sec>
</sec>
</body>
<back>
<sec sec-type="ethics-statement" id="s5">
<title>Ethics Statement</title>
<p>Our study was based on a publicly available GBD database (GHDx). All data is publicly available and open access online at (<ext-link ext-link-type="uri" xlink:href="http://ghdx.healthdata.org/gbd-results-tool">http://ghdx.healthdata.org/gbd-results-tool</ext-link>). Therefore, ethical approval is not applicable for our study.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author Contributions</title>
<p>GZ, HM, QS, GM, and FS designed the study; GZ, HM, and QS acquired the data and performed the statistical analysis; GZ, HM, and QS drafted the manuscript; GZ, HM, QS, YC, XZ, AD, GM, and FS discussed the results and critically revised the manuscript for important intellectual content; HW, YC, ZW, XZ, QM, DL, and CZ approved the final version before submission. GZ, HM, and QS have contributed equally to this work. GM and FS are equal corresponding authors in this study. GZ, HM, and QS had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that they do not have any conflicts of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI Statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>The authors would like to sincerely thank the Global Burden of Disease Study 2021 (GBD 2021) and GBD 2021 collaborators for providing valuable data used in this study.</p>
</ack>
<sec sec-type="supplementary-material" id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.ssph-journal.org/articles/10.3389/ijph.2026.1608765/full#supplementary-material">https://www.ssph-journal.org/articles/10.3389/ijph.2026.1608765/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2019 Diseases and Injuries Collaborators</collab>. <article-title>Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet</source> (<year>2020</year>) <volume>396</volume>(<issue>10258</issue>):<fpage>1204</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30925-9</pub-id>
<pub-id pub-id-type="pmid">33069326</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>ElSayed</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Aleppo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Aroda</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Bannuru</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Bruemmer</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023</article-title>. <source>Diabetes Care</source> (<year>2023</year>) <volume>46</volume>(<issue>Suppl. 1</issue>):<fpage>S19</fpage>&#x2013;<lpage>s40</lpage>. <pub-id pub-id-type="doi">10.2337/dc23-S002</pub-id>
<pub-id pub-id-type="pmid">36507649</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saeedi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Karuranga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pinkepank</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ogurtsova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>BB</given-names>
</name>
<etal/>
</person-group> <article-title>IDF Diabetes Atlas: Global, Regional and country-level Diabetes Prevalence Estimates for 2021 and Projections for 2045</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2022</year>) <volume>183</volume>:<fpage>109119</fpage>. <pub-id pub-id-type="doi">10.1016/j.diabres.2021.109119</pub-id>
<pub-id pub-id-type="pmid">34879977</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2021 Diabetes Collaborators</collab>. <article-title>Global, Regional, and National Burden of Diabetes from 1990 to 2021, with Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet</source> (<year>2023</year>) <volume>402</volume>(<issue>10397</issue>):<fpage>203</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(23)01301-6</pub-id>
<pub-id pub-id-type="pmid">37356446</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salas-Salvad&#xf3;</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guasch-Ferr&#xe9;</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Estruch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Clish</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Ros</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome</article-title>. <source>J Nutr</source> (<year>2015</year>) <volume>146</volume>(<issue>4</issue>):<fpage>920s</fpage>&#x2013;<lpage>927s</lpage>. <pub-id pub-id-type="doi">10.3945/jn.115.218487</pub-id>
<pub-id pub-id-type="pmid">26962178</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jannasch</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kr&#xf6;ger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>MB</given-names>
</name>
</person-group>. <article-title>Dietary Patterns and Type 2 Diabetes: A Systematic Literature Review and Meta-Analysis of Prospective Studies</article-title>. <source>J Nutr</source> (<year>2017</year>) <volume>147</volume>(<issue>6</issue>):<fpage>1174</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.3945/jn.116.242552</pub-id>
<pub-id pub-id-type="pmid">28424256</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aune</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Norat</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leitzmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tonstad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vatten</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Physical Activity and the Risk of Type 2 Diabetes: A Systematic Review and dose-response meta-analysis</article-title>. <source>Eur J Epidemiol</source> (<year>2015</year>) <volume>30</volume>(<issue>7</issue>):<fpage>529</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1007/s10654-015-0056-z</pub-id>
<pub-id pub-id-type="pmid">26092138</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Talaei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>FB</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Relation of Active, Passive, and Quitting Smoking with Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2015</year>) <volume>3</volume>(<issue>12</issue>):<fpage>958</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-8587(15)00316-2</pub-id>
<pub-id pub-id-type="pmid">26388413</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knott</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis of More Than 1.9 Million Individuals From 38 Observational Studies</article-title>. <source>Diabetes Care</source> (<year>2015</year>) <volume>38</volume>(<issue>9</issue>):<fpage>1804</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.2337/dc15-0710</pub-id>
<pub-id pub-id-type="pmid">26294775</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>XH</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Association Between Alcohol Consumption and the Risk of Incident Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis</article-title>. <source>Am J Clin Nutr</source> (<year>2016</year>) <volume>103</volume>(<issue>3</issue>):<fpage>818</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.115.114389</pub-id>
<pub-id pub-id-type="pmid">26843157</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegel</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Bullard</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Imperatore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Albright</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mercado</surname>
<given-names>CI</given-names>
</name>
<etal/>
</person-group> <article-title>Prevalence of Major Behavioral Risk Factors for Type 2 Diabetes</article-title>. <source>Diabetes Care</source> (<year>2018</year>) <volume>41</volume>(<issue>5</issue>):<fpage>1032</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2337/dc17-1775</pub-id>
<pub-id pub-id-type="pmid">29500166</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Gregg</surname>
<given-names>EW</given-names>
</name>
<etal/>
</person-group> <article-title>Cardiovascular Mortality, all-cause Mortality, and Diabetes Incidence After Lifestyle Intervention for People with Impaired Glucose Tolerance in the Da Qing Diabetes Prevention Study: A 23-Year Follow-Up Study</article-title>. <source>Lancet Diabetes Endocrinol</source> (<year>2014</year>) <volume>2</volume>(<issue>6</issue>):<fpage>474</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-8587(14)70057-9</pub-id>
<pub-id pub-id-type="pmid">24731674</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolb</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Environmental/Lifestyle Factors in the Pathogenesis and Prevention of Type 2 Diabetes</article-title>. <source>BMC Med</source> (<year>2017</year>) <volume>15</volume>(<issue>1</issue>):<fpage>131</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-017-0901-x</pub-id>
<pub-id pub-id-type="pmid">28720102</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2019</collab> <article-title>Dementia Forecasting Collaborators. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet Public Health</source> (<year>2022</year>) <volume>7</volume>(<issue>2</issue>):<fpage>e105</fpage>&#x2013;<lpage>e125</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(21)00249-8</pub-id>
<pub-id pub-id-type="pmid">34998485</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2021 Risk Factors Collaborators</collab>. <article-title>Global Burden and Strength of Evidence for 88 Risk Factors in 204 Countries and 811 Subnational Locations, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet</source> (<year>2024</year>) <volume>403</volume>(<issue>10440</issue>):<fpage>2162</fpage>&#x2013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00933-4</pub-id>
<pub-id pub-id-type="pmid">38762324</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>JX</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>FF</given-names>
</name>
<etal/>
</person-group> <article-title>Epidemiological Trends of Subarachnoid Hemorrhage at Global, Regional, and National Level: A Trend Analysis Study From 1990 to 2021</article-title>. <source>Mil Med Res</source> (<year>2024</year>) <volume>11</volume>(<issue>1</issue>):<fpage>46</fpage>. <pub-id pub-id-type="doi">10.1186/s40779-024-00551-6</pub-id>
<pub-id pub-id-type="pmid">38992778</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2021 Diseases and Injuries Collaborators</collab>. <article-title>Global Incidence, Prevalence, Years Lived with Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021</article-title>. <source>Lancet</source> (<year>2024</year>) <volume>403</volume>(<issue>10440</issue>):<fpage>2133</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00757-8</pub-id>
<pub-id pub-id-type="pmid">38642570</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2020 Alcohol Collaborators</collab>. <article-title>Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020</article-title>. <source>Lancet</source> (<year>2022</year>) <volume>400</volume>(<issue>10347</issue>):<fpage>185</fpage>&#x2013;<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(22)00847-9</pub-id>
<pub-id pub-id-type="pmid">35843246</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>You</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group> <article-title>Temporal Trend and Global Burden of Type 2 Diabetes Attributable to Non-Optimal Temperature, 1990-2019: An Analysis for the Global Burden of Disease Study 2019</article-title>. <source>Environ Sci Pollut Res Int</source> (<year>2023</year>) <volume>30</volume>(<issue>34</issue>):<fpage>82686</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1007/s11356-023-28225-1</pub-id>
<pub-id pub-id-type="pmid">37328723</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clegg</surname>
<given-names>LX</given-names>
</name>
<name>
<surname>Hankey</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Feuer</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>BK</given-names>
</name>
</person-group>. <article-title>Estimating Average Annual per Cent Change in Trend Analysis</article-title>. <source>Stat Med</source> (<year>2009</year>) <volume>28</volume>(<issue>29</issue>):<fpage>3670</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1002/sim.3733</pub-id>
<pub-id pub-id-type="pmid">19856324</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WQ</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>WQ</given-names>
</name>
<name>
<surname>He</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>YX</given-names>
</name>
<etal/>
</person-group> <article-title>Global Trends in Incidence and Mortality of Nasopharyngeal Carcinoma</article-title>. <source>Cancer Lett</source> (<year>2016</year>) <volume>374</volume>(<issue>1</issue>):<fpage>22</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2016.01.040</pub-id>
<pub-id pub-id-type="pmid">26828135</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Q</given-names>
</name>
<etal/>
</person-group> <article-title>Changing Trends in the Disease Burden of Esophageal Cancer in China from 1990 to 2017 and Its Predicted Level in 25 Years</article-title>. <source>Cancer Med</source> (<year>2021</year>) <volume>10</volume>(<issue>5</issue>):<fpage>1889</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1002/cam4.3775</pub-id>
<pub-id pub-id-type="pmid">33586344</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Bayesian Age-Period-Cohort Prediction of Mortality of Type 2 Diabetic Kidney Disease in China: A Modeling Study</article-title>. <source>Front Endocrinol (Lausanne)</source> (<year>2021</year>) <volume>12</volume>:<fpage>767263</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2021.767263</pub-id>
<pub-id pub-id-type="pmid">34777260</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>WQ</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>HM</given-names>
</name>
</person-group>. <article-title>Bayesian Age-Period-Cohort Prediction of Lung Cancer Incidence in China</article-title>. <source>Thorac Cancer</source> (<year>2011</year>) <volume>2</volume>(<issue>4</issue>):<fpage>149</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1111/j.1759-7714.2011.00062.x</pub-id>
<pub-id pub-id-type="pmid">27755842</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weisman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fazli</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Johns</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Booth</surname>
<given-names>GL</given-names>
</name>
</person-group>. <article-title>Evolving Trends in the Epidemiology, Risk Factors, and Prevention of Type 2 Diabetes: A Review</article-title>. <source>Can J Cardiol</source> (<year>2018</year>) <volume>34</volume>(<issue>5</issue>):<fpage>552</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2018.03.002</pub-id>
<pub-id pub-id-type="pmid">29731019</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forray</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Coman</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Simonescu-Colan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mazga</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Chereche&#x15f;</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Borzan</surname>
<given-names>CM</given-names>
</name>
</person-group>. <article-title>The Global Burden of Type 2 Diabetes Attributable to Dietary Risks: Insights from the Global Burden of Disease Study 2019</article-title>. <source>Nutrients</source> (<year>2023</year>) <volume>15</volume>(<issue>21</issue>):<fpage>4613</fpage>. <pub-id pub-id-type="doi">10.3390/nu15214613</pub-id>
<pub-id pub-id-type="pmid">37960266</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foliaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pearce</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Prevention and Control of Diabetes in Pacific People</article-title>. <source>Bmj</source> (<year>2003</year>) <volume>327</volume>(<issue>7412</issue>):<fpage>437</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.327.7412.437</pub-id>
<pub-id pub-id-type="pmid">12933734</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flood</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Seiglie</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tschida</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Theilmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marcus</surname>
<given-names>ME</given-names>
</name>
<etal/>
</person-group> <article-title>The State of Diabetes Treatment Coverage in 55 Low-Income and Middle-Income Countries: A Cross-Sectional Study of Nationally Representative, Individual-Level Data in 680 102 Adults</article-title>. <source>Lancet Healthy Longev</source> (<year>2021</year>) <volume>2</volume>(<issue>6</issue>):<fpage>e340</fpage>&#x2013;<lpage>e351</lpage>. <pub-id pub-id-type="doi">10.1016/s2666-7568(21)00089-1</pub-id>
<pub-id pub-id-type="pmid">35211689</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otero</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lassailly</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>X</given-names>
</name>
</person-group>. <article-title>Exploring the Links Between Types 2 Diabetes and Liver-Related Complications: A Comprehensive Review</article-title>. <source>United Eur Gastroenterol J</source> (<year>2024</year>) <volume>12</volume>(<issue>2</issue>):<fpage>240</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1002/ueg2.12508</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>SantaCruz-Calvo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bharath</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pugh</surname>
<given-names>G</given-names>
</name>
<name>
<surname>SantaCruz-Calvo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lenin</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Lutshumba</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Adaptive Immune Cells Shape Obesity-Associated Type 2 Diabetes Mellitus and less Prominent Comorbidities</article-title>. <source>Nat Rev Endocrinol</source> (<year>2022</year>) <volume>18</volume>(<issue>1</issue>):<fpage>23</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-021-00575-1</pub-id>
<pub-id pub-id-type="pmid">34703027</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stocks</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zierath</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>Post-Translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity</article-title>. <source>Endocr Rev</source> (<year>2022</year>) <volume>43</volume>(<issue>4</issue>):<fpage>654</fpage>&#x2013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1210/endrev/bnab038</pub-id>
<pub-id pub-id-type="pmid">34730177</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Healthy Lifestyle Behaviors, Mediating Biomarkers, and Risk of Microvascular Complications Among Individuals with Type 2 Diabetes: A Cohort Study</article-title>. <source>Plos Med</source> (<year>2023</year>) <volume>20</volume>(<issue>1</issue>):<fpage>e1004135</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1004135</pub-id>
<pub-id pub-id-type="pmid">36626356</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Interactions of Genes with Alcohol Consumption Affect Insulin Sensitivity and Beta Cell Function</article-title>. <source>Diabetologia</source> (<year>2025</year>) <volume>68</volume>(<issue>1</issue>):<fpage>116</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-024-06291-5</pub-id>
<pub-id pub-id-type="pmid">39425782</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>YZ</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ran</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>SQ</given-names>
</name>
</person-group>. <article-title>Association Between Alcohol Consumption and Risk of Type 2 Diabetes in Japan: A Population-Base Longitudinal Cohort Study</article-title>. <source>Sci Rep</source> (<year>2025</year>) <volume>15</volume>(<issue>1</issue>):<fpage>630</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-024-84597-5</pub-id>
<pub-id pub-id-type="pmid">39753739</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="book">
<collab>World Health Organization</collab>. <source>Global Status Report on Alcohol and Health 2018</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name> (<year>2018</year>).</mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manthey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shield</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Rylett</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>OSM</given-names>
</name>
<name>
<surname>Probst</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Global Alcohol Exposure Between 1990 and 2017 and Forecasts Until 2030: A Modelling Study</article-title>. <source>Lancet</source> (<year>2019</year>) <volume>393</volume>(<issue>10190</issue>):<fpage>2493</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)32744-2</pub-id>
<pub-id pub-id-type="pmid">31076174</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herzog</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ahlqvist</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Alfredsson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Groop</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hjort</surname>
<given-names>R</given-names>
</name>
<name>
<surname>L&#xf6;fvenborg</surname>
<given-names>JE</given-names>
</name>
<etal/>
</person-group> <article-title>Combined Lifestyle Factors and the Risk of LADA and Type 2 Diabetes - Results from a Swedish Population-Based Case-Control Study</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2021</year>) <volume>174</volume>:<fpage>108760</fpage>. <pub-id pub-id-type="doi">10.1016/j.diabres.2021.108760</pub-id>
<pub-id pub-id-type="pmid">33744376</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertoni</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Krop</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Brancati</surname>
<given-names>FL</given-names>
</name>
</person-group>. <article-title>Diabetes-Related Morbidity and Mortality in a National Sample of U.S. Elders</article-title>. <source>Diabetes Care</source> (<year>2002</year>) <volume>25</volume>(<issue>3</issue>):<fpage>471</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.2337/diacare.25.3.471</pub-id>
<pub-id pub-id-type="pmid">11874932</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Laiteerapong</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>John</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Moffet</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Karter</surname>
<given-names>AJ</given-names>
</name>
</person-group>. <article-title>Rates of Complications and Mortality in Older Patients with Diabetes Mellitus: The Diabetes and Aging Study</article-title>. <source>JAMA Intern Med</source> (<year>2014</year>) <volume>174</volume>(<issue>2</issue>):<fpage>251</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2013.12956</pub-id>
<pub-id pub-id-type="pmid">24322595</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basanta-Alario</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Ferri</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Civera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Herv&#xe1;s</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ascaso</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Real</surname>
<given-names>JT</given-names>
</name>
</person-group>. <article-title>Differences in Clinical and Biological Characteristics and Prevalence of Chronic Complications Related to Aging in Patients with Type 2 Diabetes</article-title>. <source>Endocrinol Nutr</source> (<year>2016</year>) <volume>63</volume>(<issue>2</issue>):<fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.endonu.2015.10.005</pub-id>
<pub-id pub-id-type="pmid">26675268</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kautzky-Willer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leutner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abrahamian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Fr&#xfc;hwald</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hoppichler</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lechleitner</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Sex and Gender-specific Aspects in Prediabetes and Diabetes Mellitus-Clinical Recommendations (Update 2023)</article-title>. <source>Wien Klin Wochenschr</source> (<year>2023</year>) <volume>135</volume>(<issue>Suppl. 1</issue>):<fpage>275</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1007/s00508-023-02185-5</pub-id>
<pub-id pub-id-type="pmid">37101049</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2019 Healthcare Access and Quality Collaborators</collab>. <article-title>Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990-2019: A Systematic Analysis from the Global Burden of Disease Study 2019</article-title>. <source>Lancet Glob Health</source> (<year>2022</year>) <volume>10</volume>(<issue>12</issue>):<fpage>e1715</fpage>&#x2013;<lpage>e1743</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(22)00429-6</pub-id>
<pub-id pub-id-type="pmid">36209761</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seidell</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Halberstadt</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The Global Burden of Obesity and the Challenges of Prevention</article-title>. <source>Ann Nutr Metab</source> (<year>2015</year>) <volume>66</volume>(<issue>Suppl. 2</issue>):<fpage>7</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1159/000375143</pub-id>
<pub-id pub-id-type="pmid">26045323</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Torre</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Pearson-Stuttard</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Islami</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fedewa</surname>
<given-names>SA</given-names>
</name>
<etal/>
</person-group> <article-title>Global Patterns in Excess Body Weight and the Associated Cancer Burden</article-title>. <source>CA Cancer J Clin</source> (<year>2019</year>) <volume>69</volume>(<issue>2</issue>):<fpage>88</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.3322/caac.21499</pub-id>
<pub-id pub-id-type="pmid">30548482</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>JCN</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Wareham</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Orchard</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>The Lancet Commission on Diabetes: Using Data to Transform Diabetes Care and Patient Lives</article-title>. <source>Lancet</source> (<year>2021</year>) <volume>396</volume>(<issue>10267</issue>):<fpage>2019</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)32374-6</pub-id>
<pub-id pub-id-type="pmid">33189186</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>The Global, Regional, and National Patterns of Change in the Burden of Congenital Birth Defects, 1990-2021: An Analysis of the Global Burden of Disease Study 2021 and Forecast to 2040</article-title>. <source>EClinicalMedicine</source> (<year>2024</year>) <volume>77</volume>:<fpage>102873</fpage>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2024.102873</pub-id>
<pub-id pub-id-type="pmid">39416384</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alsalhe</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Chalghaf</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ricc&#xf2;</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bragazzi</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The Global Burden of Disease Attributable to High Body Mass Index in 195 Countries and Territories, 1990-2017: An Analysis of the Global Burden of Disease Study</article-title>. <source>Plos Med</source> (<year>2020</year>) <volume>17</volume>(<issue>7</issue>):<fpage>e1003198</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1003198</pub-id>
<pub-id pub-id-type="pmid">32722671</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magkos</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hjorth</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Astrup</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Diet and Exercise in the Prevention and Treatment of Type 2 Diabetes Mellitus</article-title>. <source>Nat Rev Endocrinol</source> (<year>2020</year>) <volume>16</volume>(<issue>10</issue>):<fpage>545</fpage>&#x2013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/s41574-020-0381-5</pub-id>
<pub-id pub-id-type="pmid">32690918</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wadi</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Cheikh</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Keung</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Investigating Intervention Components and Their Effectiveness in Promoting Environmentally Sustainable Diets: A Systematic Review</article-title>. <source>Lancet Planet Health</source> (<year>2024</year>) <volume>8</volume>(<issue>6</issue>):<fpage>e410</fpage>&#x2013;<lpage>e422</lpage>. <pub-id pub-id-type="doi">10.1016/S2542-5196(24)00064-0</pub-id>
<pub-id pub-id-type="pmid">38849183</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kilian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lemp</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Llamosas-Falc&#xf3;n</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>WC</given-names>
</name>
<etal/>
</person-group> <article-title>Reducing Alcohol Use Through Alcohol Control Policies in the General Population and Population Subgroups: A Systematic Review and meta-analysis</article-title>. <source>EClinicalMedicine</source> (<year>2023</year>) <volume>59</volume>:<fpage>101996</fpage>. <pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101996</pub-id>
<pub-id pub-id-type="pmid">37256096</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Badaras</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferreira-Borges</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Galkus</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gostautaite Midttun</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gobi&#x146;a</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Impact of the WHO &#x201c;Best Buys&#x201d; for Alcohol Policy on Consumption and Health in the Baltic Countries and Poland 2000-2020</article-title>. <source>Lancet Reg Health Eur</source> (<year>2023</year>) <volume>33</volume>:<fpage>100704</fpage>. <pub-id pub-id-type="doi">10.1016/j.lanepe.2023.100704</pub-id>
<pub-id pub-id-type="pmid">37953993</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal">
<collab>GBD 2019 Risk Factors Collaborators</collab>. <article-title>Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019</article-title>. <source>Lancet</source> (<year>2020</year>) <volume>396</volume>(<issue>10258</issue>):<fpage>1223</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30752-2</pub-id>
<pub-id pub-id-type="pmid">33069327</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1002523/overview">Olaf von dem Knesebeck</ext-link>, University Medical Center Hamburg-Eppendorf, Germany</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> One reviewer who chose to remain anonymous</p>
</fn>
</fn-group>
</back>
</article>